These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34198107)

  • 1. Glucagon delivery - An overview of current and future devices.
    Rabinovich A; Priefer R
    Diabetes Metab Syndr; 2021; 15(4):102155. PubMed ID: 34198107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue.
    Wilson LM; Castle JR
    J Diabetes Sci Technol; 2018 Jul; 12(4):847-853. PubMed ID: 29415555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
    Pontiroli AE; Ceriani V
    Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
    GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY
    Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.
    Haymond MW; Schreiner B
    Diabetes Care; 2001 Apr; 24(4):643-5. PubMed ID: 11315823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon: Delivery advancements for hypoglycemia management.
    Kumar S; Sanap SN; Pandey P; Khopade A; Sawant KK
    Int J Pharm; 2024 Mar; 652():123785. PubMed ID: 38224759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.
    Hövelmann U; Bysted BV; Mouritzen U; Macchi F; Lamers D; Kronshage B; Møller DV; Heise T
    Diabetes Care; 2018 Mar; 41(3):531-537. PubMed ID: 29273578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Preparations of Glucagon for the Prevention and Treatment of Hypoglycemia.
    Hawkes CP; De Leon DD; Rickels MR
    Curr Diab Rep; 2019 Sep; 19(10):97. PubMed ID: 31493043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Developments in Glucagon Treatment for Hypoglycemia.
    Story LH; Wilson LM
    Drugs; 2022 Jul; 82(11):1179-1191. PubMed ID: 35932416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions About Glucagon Delivery Devices for Severe Hypoglycemia: Qualitative Research With Patients, Caregivers, and Acquaintances.
    Bajpai SK; Cambron-Mellott MJ; Peck E; Poon JL; Wang Q; Mitchell BD; Babrowicz J; Child CJ; Raibulet NK; Beusterien K
    Clin Ther; 2019 Oct; 41(10):2073-2089.e6. PubMed ID: 31526655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Mini-Dose Glucagon for Treatment of Nonsevere Hypoglycemia in Adults With Type 1 Diabetes.
    Haymond MW; DuBose SN; Rickels MR; Wolpert H; Shah VN; Sherr JL; Weinstock RS; Agarwal S; Verdejo AS; Cummins MJ; Newswanger B; Beck RW;
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2994-3001. PubMed ID: 28591776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
    Haidar A; Legault L; Dallaire M; Alkhateeb A; Coriati A; Messier V; Cheng P; Millette M; Boulet B; Rabasa-Lhoret R
    CMAJ; 2013 Mar; 185(4):297-305. PubMed ID: 23359039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.
    Rickels MR; Ruedy KJ; Foster NC; Piché CA; Dulude H; Sherr JL; Tamborlane WV; Bethin KE; DiMeglio LA; Wadwa RP; Ahmann AJ; Haller MJ; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
    Diabetes Care; 2016 Feb; 39(2):264-70. PubMed ID: 26681725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Glucagon for Severe Hypoglycemia.
    Grant JS; Graven LJ
    Home Healthc Now; 2017 Feb; 35(2):114-115. PubMed ID: 28157777
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.
    Sherr JL; Ruedy KJ; Foster NC; Piché CA; Dulude H; Rickels MR; Tamborlane WV; Bethin KE; DiMeglio LA; Fox LA; Wadwa RP; Schatz DA; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
    Diabetes Care; 2016 Apr; 39(4):555-62. PubMed ID: 26884472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Glucagon in Automated Insulin Delivery.
    Wilson LM; Jacobs PG; Castle JR
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):179-202. PubMed ID: 31980117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal glucagon in the treatment of hypoglycaemic attacks in children: experience at a summer camp.
    Slama G; Reach G; Cahane M; Quetin C; Villanove-Robin F
    Diabetologia; 1992 Apr; 35(4):398. PubMed ID: 1516770
    [No Abstract]   [Full Text] [Related]  

  • 18. Intranasal Glucagon.
    Kalra S; Dhingra M
    J Pak Med Assoc; 2019 Aug; 69(8):1219-1221. PubMed ID: 31431785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Needle-free nasal delivery of glucagon for treatment of diabetes-related severe hypoglycemia: toxicology of polypropylene resin used in delivery device.
    Reno FE; Edwards CN; Bendix Jensen M; Török-Bathó M; Esdaile DJ; Piché C; Triest M; Carballo D
    Cutan Ocul Toxicol; 2016 Sep; 35(3):242-7. PubMed ID: 26426957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.
    Stenninger E; Aman J
    Diabetologia; 1993 Oct; 36(10):931-5. PubMed ID: 8243872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.